Kavthekar Atul 4
4 · P3 Health Partners Inc. · Filed Dec 14, 2022
Insider Transaction Report
Form 4
Kavthekar Atul
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-12-12+600,000→ 600,000 totalExercise: $3.70Exp: 2032-12-12→ Class A Common Stock (600,000 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable with respect to 25% of the shares on December 12, 2023 (the "Initial Vesting Date"), and the remaining 75% will vest in equal annual installments over the following three years on each anniversary of the Initial Vesting Date, subject to the Reporting Person's continued service through the applicable vesting date.